Breaking News Instant updates and real-time market news.

TLRY

Tilray

$80.75

1.08 (1.36%)

, SBUX

Starbucks

$64.18

0.32 (0.50%)

09:13
01/11/19
01/11
09:13
01/11/19
09:13

Fly Intel: Pre-market Movers

HIGHER: Tilray (TLRY), up 18% after Privateer Holdings issued a statement emphasizing it does not have plans to register, sell or distribute the 75M shares that it owns in the company... Flotek (FTK), up 1111% after announcing it will sell Florida Chemical to Archer Daniel Midlands (ADM) for $175M and plans to use some of the proceeds on organic growth capital projects... Embraer (ERJ), up 6% after announcing Brazil government approval for Boeing (BA) merger... Netflix (NFLX), up 2% after Raymond James analyst Justin Patterson upgraded the stock to Strong Buy from Outperform and UBS analyst Eric Sheridan also upgraded the stock to Buy from Neutral... AB InBev (BUD), up 3% after Reuters reports speculation about its Asia business IPO. LOWER: Activision-Blizzard (ATVI), down 8.5% after announcing Bungie will receive Destiny franchise publishing rights... PG&E (PCG), down 6% after Moody's cut its bond rating to junk... Starbucks (SBUX), down 3% after after Goldman Sachs analyst Karen Holthouse downgraded shares to Neutral and lowered her price target for the stock to $68 from $75... Gap (GPS), down 3% after Barclays analyst Chethan Mallela double downgraded the stock to Underweight from Overweight and cut his price target for the shares to $25 from $33. The analyst believes "challenging" traffic trends and "difficult" comparisons cloud visibility into the company's sales growth momentum... WW (WTW), down 5% after JPMorgan analyst Christina Brathwaite downgraded WW, formerly known as Weight Watchers, to Neutral and lowered her price target for the shares to $37 from $70. The analyst's early in the year channel checks point to a weak start to 2019 for the company... Yum! Brands (YUM), down 3% after Goldman Sachs' Holthouse downgraded the stock to Sell and lowered her price target for the shares to $76 from $83. The company's "peak valuations versus the market" are "overly dismissive of a number of risks," Holthouse tells investors.

TLRY

Tilray

$80.75

1.08 (1.36%)

SBUX

Starbucks

$64.18

0.32 (0.50%)

NFLX

Netflix

$324.77

4.81 (1.50%)

ERJ

Embraer

$22.63

-0.47 (-2.03%)

BA

Boeing

$352.53

8.6 (2.50%)

BUD

AB InBev

$70.77

0.56 (0.80%)

ATVI

Activision Blizzard

$51.35

0.52 (1.02%)

PCG

PG&E

$17.75

-0.07 (-0.39%)

FTK

Flotek

$1.42

-0.025 (-1.74%)

ADM

Archer Daniels

$43.38

0.31 (0.72%)

GPS

Gap

$25.25

-0.8 (-3.07%)

WTW

WW

$35.02

-1.02 (-2.83%)

YUM

Yum! Brands

$91.79

0.63 (0.69%)

  • 14

    Jan

  • 24

    Jan

  • 30

    Jan

  • 12

    Feb

  • 03

    Mar

  • 27

    Mar

  • 28

    May

TLRY Tilray
$80.75

1.08 (1.36%)

12/18/18
COWN
12/18/18
NO CHANGE
COWN
Outperform
Cowen sees Sandoz deal as reinforcing Tilray's competitive positioning
Tilray's (TLRY) expanded global partnership with Novartis (NVS) division Sandoz can not only help expand its reach with pharmacists, physicians and distributors, it can also help Tilray capture early share in new medical cannabis markets as they come online, Cowen analyst Vivien Azer tells investors in a research note. Further, the analyst believes the partnership also helps legitimize cannabis in international markets, which could help influence countries considering medical cannabis legalization. Azer estimates international will represent 15% of Tilray's revenue in fiscal 2020 and 22% in fiscal 2021. Not only does the deal allow Tilray to expand geographic reach, but also to grow at scale, says Azer. And most notably, the Sandoz deal reinforces Tilray's competitive positioning, adds the analyst, who keeps an Outperform rating on the shares with a $150 price target. The stock in morning trading is up 9%, or $5.98, to $71.87.
11/14/18
BNCH
11/14/18
NO CHANGE
Target $200
BNCH
Buy
Tilray reported 'strong' Q3 sales without recreational cannabis, says Benchmark
Benchmark analyst Mike Hickey said Tilray reported "strong" Q3 sales even though the company did not recognize sales from recreational cannabis use in the quarter. Recreational use experienced a slow start, primarily due to the timing of licenses, distribution and retail infrastructure, as expected, said Hickey, who adds that there "appears to be exceedingly strong demand" from Canadians. He has raised his Q4 sales forecast based on increased production and presumed ongoing strong consumer demand and keeps a Buy rating on Tilray with a $200 price target.
01/09/19
PIPR
01/09/19
INITIATION
PIPR
Overweight
Piper Jaffray rolls out bullish research coverage on Canopy Growth, Tilray
Piper Jaffray analyst Michael Lavery initiated coverage of Canopy Growth (CGC) and Tilray (TLRY) with Overweight ratings and price targets of $40 and $90, respectively. The analyst believes the global Cannabis market has the potential to reach $250B-$500B over the long term and $15B-$50B in the near term. The industry's long-term growth opportunities are significant, both from transitioning illicit trade to legal sales and from transitioning sales in health and wellness categories to cannabidiol-infused products, Lavery tells investors in a research note. The analyst expects recreational use to source from illicit trade and alcohol, medical use to source from other medical treatments, and non-psychoactive CBD-infused cannabis products to source users from food, beverage, and personal care categories. Over 25 countries have legal marijuana use today, he points out. Lavery believes federal legalization in the U.S. could potentially come in the next five years. Further, the analyst expects capital flow into the sector will likely continue.
01/09/19
PIPR
01/09/19
INITIATION
Target $90
PIPR
Overweight
Tilray initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Michael Lavery initiated coverage of Tilray with an Overweight rating and $90 price target. The analyst expects "strong" industry growth long-term, and believes Tilray is well positioned to be one of several likely winners given its relationships in medical, in the U.S., and in beverages. Lavery consider the company's initial public offering lock-up expiry to be a near-term risk, especially with 77% insider ownership, but his 12-month Overweight view is based on its fundamental outlook. He pegs Tilray's market opportunity at $15B-$50B in the near-term, and potentially $250B-$500B over the longer term.
SBUX Starbucks
$64.18

0.32 (0.50%)

12/19/18
JPMS
12/19/18
NO CHANGE
Target $70
JPMS
Overweight
JPMorgan likes shares of Starbucks at current levels
JPMorgan analyst John Ivankoe says he likes shares of Starbucks at current levels after taking a group of investors to the company's Seattle headquarters. Improved visibility into U.S. comp improvement, driven by various sales-driving initiatives along with 6%-7% global unit growth, will allow Starbucks to sustain a premium multiple, Ivankoe tells investors in a research note. He keeps an Overweight rating on the shares with a $70 price target.
12/14/18
BMOC
12/14/18
NO CHANGE
Target $63
BMOC
Market Perform
Starbucks price target raised to $63 from $58 at BMO Capital
BMO Capital analyst Andrew Strelzik raised his price target on Starbucks to $63 after its Investor Day presentation. The analyst notes that the company's "lowering of long-term algorithm may have caught the market by surprise", but his takeaway from the event is "incrementally positive" based on the CEO commentary around comps estimates and slowing net store openings reducing "cannibalization concerns". Strelzik keeps his Market Perform rating on Starbucks however, stating that its valuation is "too expensive" to get more constructive.
12/14/18
RBCM
12/14/18
NO CHANGE
Target $74
RBCM
Outperform
Starbucks price target raised to $74 from $68 at RBC Capital
RBC Capital analyst David Palmer raised his price target on Starbucks to $74 and kept his Outperform rating, saying that its Investor Day presentation yesterday gave him more confidence in the company's comps trajectory. The analyst contends that Starbucks represents a "unique" blend of mid-single-digit unit growth and "best-in-class return on investment" that is further reinforced by its "digital capabilities, exposure to the growing specialty coffee segment, and a strong brand image."
01/11/19
GSCO
01/11/19
DOWNGRADE
Target $68
GSCO
Neutral
Starbucks downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Karen Holthouse downgraded Starbucks to Neutral and lowered her price target for the shares to $68 from $75. The coffee giant closed yesterday up 31c to $64.19. The analyst remains "reasonably confident" that Starbucks' initiatives to drive digital engagement can lead to a "more stable" 3%-4% comp trajectory in the U.S. over the next few years. However, its valuation has "rapidly re-rated" to reflect this, and gift cards and digital trends could be points of caution in fiscal Q1, Holthouse tells investors in a research note. Further, she has "incremental concerns" regarding the China macro environment and the company's comp trajectory in that region. Other consumer companies, like Apple (AAPL) and McDonald's (MCD), have noted weakness in China, the analyst points out. Holthouse this morning also upgraded Texas Roadhouse (TXRH) to Buy from Neutral and downgraded Yum! Brands (YUM) to Sell from Neutral.
NFLX Netflix
$324.77

4.81 (1.50%)

01/11/19
RAJA
01/11/19
UPGRADE
RAJA
Strong Buy
Netflix upgraded to Strong Buy from Outperform at Raymond James
01/11/19
MSCO
01/11/19
NO CHANGE
Target $430
MSCO
Overweight
Netflix price target lowered to $430 from $475 at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne lowered his price target on Netflix (NFLX) shares to $430 from $475 as he factored in his "modestly lower" view on long-term margins and the broader de-rating of the stock in the market. While he currently forecasts 27M global paid net adds in 2019, Swinburne has tempered his 2019 ARPU growth view, noting that Netflix has not implemented broad price increases as of yet. He still believes Netflix's long-term pricing power remains intact, though he is now taking a more conservative approach to ARPU growth in emerging markets longer term. Swinburne keeps an Overweight rating on Netflix, citing the nearly $500B global TV market it has the potential to address and his view that while many traditional TV studio owners, like Disney (DIS), will pivot to streaming, most likely will not.
01/11/19
RAJA
01/11/19
UPGRADE
Target $450
RAJA
Strong Buy
Raymond James upgrades Netflix to Strong Buy, sees material profitability ahead
As previously reported, Raymond James analyst Justin Patterson upgraded Netflix to Strong Buy from Outperform and raised his price target on the stock to $450 from $435. Netflix is approaching a profit inflection, as the company's front-loaded headcount investments will be leveraged and lead to an operating margin inflection, contends Patterson. His survey work shows Netflix's traction in film is helping it gain share against linear TV and he sees meaningful potential for Netflix to succeed in film, which Patterson believes should aid subscriber growth, retention and pricing power, he added. Last night, UBS analyst Eric Sheridan also upgraded Netflix to Buy from Neutral and raised his price target for the shares to $410 from $400.
01/11/19
UBSW
01/11/19
UPGRADE
Target $410
UBSW
Buy
UBS is 'taking the blindfold off,' upgrades Netflix shares to Buy
UBS analyst Eric Sheridan last night upgraded Netflix to Buy from Neutral and raised his price target for the shares to $410 from $400. The streaming giant closed yesterday up $4.70 to $324.66. After six months of stock underperformance as key debates emerged about competition, margins and free cash flow, the debates are better understood by investors and reflected in the current stock price, Sheridan tells investors in a research note partially titled "Taking The Blindfold Off." The analyst sees share upside over the near-to-medium term to subscriber growth. Current subscriber metrics such as growth, churn, spend and consumption are tracking inline to better than management's Q4 guidance and commentary, Sheridan says, citing his firm's Evidence Lab.
ERJ Embraer
$22.63

-0.47 (-2.03%)

12/18/18
COWN
12/18/18
NO CHANGE
Target $445
COWN
Outperform
Cowen says Boeing dividend hike topped expectation
Cowen analyst Cai von Rumohr said Boeing (BA) remains a top pick given its estimated 2019 free cash flow yield and peer high dividend. He noted that the company's dividend hike announcement topped his estimate and he said the finalized joint venture announcement with Embraer (ERJ) offers large, value accretive cost/revenue synergies. Rumohr reiterated his Outperform rating and $445 price target on Boeing shares.
09/26/18
BRSE
09/26/18
UPGRADE
BRSE
Outperform
Embraer upgraded to Outperform from Neutral at Bradesco
Bradesco analyst Victor Mizusaki upgraded Embraer to Outperform and raised its price target to $28 from $23 citing attractive risk/reward.
08/24/18
08/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Buy from Hold at SunTrust with analyst Matthew Thornton saying the pullback after the Q2 subscriber miss was driven in part by the interest in World Cup viewing. 2. Sanderson Farms (SAFM) upgraded to Overweight from Equal Weight at Stephens with analyst Farha Aslam citing the company's Q3 results and saying she believes weak chicken fundamentals are now priced into the shares. 3. Children's Place (PLCE) upgraded to Buy from Neutral at Monness Crespi analyst Jim Chartier saying the modest sell-off in shares following strong Q2 results provides a buying opportunity. 4. Mylan (MYL) upgraded to Outperform from In Line at Evercore ISI. 5. Embraer (ERJ) upgraded to Hold from Underperform at Santander. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/19/18
10/19/18
NO CHANGE

Embraer delivers 15 commercial and 24 executive jets in Q3
Embraer delivered 15 jets to the commercial aviation market and 24 business jets in Q3, being 17 light jets and 7 large jets. On September 30, Embraer's firm order backlog totaled $13.6B. In the commercial aviation market, Embraer forecasted in its Market Outlook a demand for 10,550 new aircraft with up to 150 seats worldwide over the next 20 years. The in-service fleet is set to increase to 16,000 aircraft, up from the 9,000 aircraft currently in operation. Market growth will drive 65% of this demand, while the remaining 35% of the projected demand will be to replace ageing aircraft. Embraer and Helvetic Airways signed a contract for a firm order of 12 E190-E2 jets during Q3. The contract also includes purchase rights for another 12 E190-E2 aircraft. Deliveries should occur between the end of 2019 and 2021. United Airlines made a firm order for 25 E175 jets in a 70-seat configuration. Deliveries will begin in 2Q19. Embraer also signed a contract with an undisclosed customer in Q3 for up to five E195-E2s, being three firm orders and two purchase rights. In addition, the company continues to work on finalizing its recent LoI for 100 E175 aircraft for Republic Airways, with the expectation that a significant portion of these jets should enter the company's backlog by the end of 2018. A total of 134 jets were removed from Embraer's backlog in Q3.
BA Boeing
$352.53

8.6 (2.50%)

01/10/19
01/10/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ship Finance (SFL) initiated with a Neutral at B. Riley FBR. 2. Wipro (WIT) initiated with a Hold at Deutsche Bank. 3. Boeing (BA), Lockheed Martin (LMT), and Raytheon (RTN) were initiated with a Positive at Susquehanna while Northrop Grumman (NOC) and General Dynamics (GD) were initiated with a Neutral. 4. Dollar General (DG) initiated with an Outperform at BMO Capital while Dollar Tree (DLTR) was initiated with a Market Perform. 5. Verint (VRNT) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/19
01/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Constellation Brands (STZ) upgraded to Buy from Neutral at Goldman Sachs and to Neutral from Sell at Guggenheim. 2. Boeing (BA) upgraded to Overweight from Equal Weight at Morgan Stanley. 3. Lockheed Martin (LMT) upgraded to Buy from Hold at Vertical Group. 4. United Continental (UAL) upgraded to Overweight from Neutral at JPMorgan while Alaska Air (ALK) was upgraded to Neutral from Underweight. 5. Twitter (TWTR) double upgraded to Buy from Underperform at BofA/Merrill with analyst Justin Post citing a survey he conducted which showed Twitter penetration increased to 48% of respondents and the percentage of users reporting deceased usage fell slightly. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/19
01/10/19
NO CHANGE

Morgan Stanley upgrades Boeing, downgrades Lockheed in A&D ratings shake-up
As previously reported, Morgan Stanley analyst Rajeev Lalwani upgraded Boeing (BA) to Overweight from Equal Weight and downgraded Lockheed Martin (LMT) to Equal Weight from Overweight as he adjusted his picks within Aerospace & Defense to focus more on those with visibility to free cash flow growth. Boeing shares are down about 15% from their highs, creating a favorable set-up, and the resilience of the EPS and free cash profile should remain in place within Commercial Aerospace, barring a downturn, Lalwani tells investors. He raised his price target on Boeing shares to $450 from $400. With the F-35 plateauing and pension tailwinds receding, Lalwani sees emerging headwinds on earnings and cash flow post 2020 for Lockheed, he said in explaining his downgrade of the stock. He lowered his price target on Lockheed shares to $300 from $366.
01/10/19
SUSQ
01/10/19
INITIATION
Target $388
SUSQ
Positive
Susquehanna says plane market remains strong, initiates Boeing at Positive
Susquehanna analyst Charles Minervino initiated Boeing with a Positive rating as he believes the commercial airplane market is still in an order upcycle. The analyst said customers need to replace aging fleets while catering to growing travel demand and the recent pullback in the stock makes the shares attractive. Minervino had a $388 price target on Boeing shares.
BUD AB InBev
$70.77

0.56 (0.80%)

11/12/18
ARGS
11/12/18
DOWNGRADE
ARGS
Hold
AB InBev downgraded to Hold from Buy at Argus
Argus analyst David Coleman downgraded Anheuser-Busch In Bev to Hold from Buy after the company cut the dividend in half, which he believes reduces the attraction of the stock to income investors. He also said the company has been "erratic" on earnings, noting that AB InBev has missed forecasts in three of the past five quarters.
01/04/19
GSCO
01/04/19
DOWNGRADE
GSCO
Neutral
AB InBev downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs downgraded AB InBev to Neutral from Buy, saying that while the company is better positioned than its industry peers, it is "not immune from rising competition".
12/11/18
OTRG
12/11/18
NO CHANGE
OTRG
MillerCoors and ABI Q4 trends lag overall US beer category, says OTR Global
OTR Global's US beer Q4 distributor checks indicate MillerCoors (TAP) and ABI (BUD) volumes lagged the overall beer category. The firm said domestic premium light beers continued to struggle, while flavored malt beverages and imports boosted overall beer volumes.
11/12/18
11/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Hold om Buy at SunTrust with analyst Matthew Thornton citing a surprising and disappointing set of Q3 results following a "stellar" first half of 2018, highlighted by the return of sales execution issues, yielding an unexpected slowdown in gross account adds and continued churn. 2. Cheesecake Factory (CAKE) downgraded to Underweight from Equal Weight at Barclays with analyst Jeffrey Bernstein saying he sees headwinds persisting following the company's "disappointing" Q3 results and views the valuation as full at current share levels. 3. Infinity Pharmaceuticals (INFI) downgraded to Underweight from Neutral at JPMorgan and to Market Perform at Wells Fargo. 4. Skyworks (SWKS) downgraded to Neutral from Buy at Citi with analyst Atif Malik saying the company is being impacted by broad smartphone weakness, disappointing unit sales of Apple's (AAPL) iPhone XR, and a high Apple concentration, which represented 39% of sales in fiscal 2019. 5. AB InBev (BUD) downgraded to Hold from Buy at Argus with analyst David Coleman citing the company's dividend cut, which he believes reduces the attraction of the stock to income investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ATVI Activision Blizzard
$51.35

0.52 (1.02%)

01/11/19
BMOC
01/11/19
NO CHANGE
Target $52
BMOC
Market Perform
Activision Blizzard price target lowered to $52 from $60 at BMO Capital
BMO Capital analyst Gerrick Johnson lowered his price target on Activision Blizzard to $52 after its announcement that it will turn the development rights to Destiny franchise to Bungie. The analyst also lowers his FY19 EPS view by 5c to $2.60 to reflect the decision while keeping his Market Perform rating on the stock. Johnson adds that while the economics of publishing Destiny games may have turned, he ponders whether the move is "too soon on what, just a few years ago, seemed a crown jewel in the Activision Publishing portfolio."
01/11/19
MKMP
01/11/19
NO CHANGE
Target $48
MKMP
Neutral
Activision Blizzard price target lowered to $48 from $68 at MKM Partners
MKM Partners analyst Eric Handler lowered his price target on Activision Blizzard to $48 and kept his Neutral rating, citing the company's "reduced financial visibility and limited capital appreciation potential" for 2019. The analyst notes that the company's portfolio is "in need of being reinvigorated, especially with Live Service", but expects 2019 to be a year of transition for Activision Blizzard as it scales down its "non-franchise games". Handler further warns that the company's earnings could decline by high-single to low-double digits in FY19, which would require a "significant downward revision in Street estimates."
01/11/19
STFL
01/11/19
NO CHANGE
STFL
Buy
Stifel sees limited FY19 financial impact to Activision from giving up Destiny
After Activision Blizzard announced last night that it plans for Bungie to assume full publishing rights for the Destiny franchise, Stifel analyst Drew Crum said he thinks the financial impact on his published 2019 estimates will be limited. The separation makes sense, as the relationship with Bungie seemingly deteriorated following what Activision management described as a disappointing performance for "Destiny 2: Forsaken" and Crum thinks this should free up resources to develop new IP and support existing franchises, such as Call of Duty live services, he said. He maintains a Buy rating on Activision Blizzard shares.
01/11/19
MSCO
01/11/19
NO CHANGE
MSCO
Overweight
More pipeline uncertainty to weigh on Activision multiple, says Morgan Stanley
After Activision Blizzard announced that Bungie would be taking over full publishing rights and responsibilities for the Destiny franchise, Morgan Stanley analyst Brian Nowak said he views this as in part due to a decision to reallocate resources away from Destiny, which has been recently underperforming the company's and his expectations. He estimates the impact to 2019 EPS to be only about 3%, but thinks that higher pipeline uncertainty, recent execution missteps and management departures will weigh on the stock's multiple. Nowak keeps an Overweight rating on Activision Blizzard shares, but said his model in under review.
PCG PG&E
$17.75

-0.07 (-0.39%)

11/19/18
MSCO
11/19/18
NO CHANGE
Target $31
MSCO
Equal Weight
PG&E break-up could be constructive to valuation, but risky, says Morgan Stanley
After California Public Utilities Commission President Michael Picker said the Commission would explore potentially breaking up PG&E, Morgan Stanley analyst Stephen Byrd said he believes a break-up could be constructive to the stock's valuation, but he also sees significant risks to such an approach, identifying the key risk as the regulator, and potentially lawmakers, seeking greater asset coverage for wildfire-related damages beyond the value of the electric utility. He also notes the risk that damages from the Camp Fire could increase from current estimates, given potential liabilities for wrongful death and for air quality damages. Byrd maintains an Equal Weight rating and $31 price target on PG&E shares.
12/10/18
WELS
12/10/18
NO CHANGE
Target $47
WELS
Outperform
PG&E price target lowered to $47 from $60 at Wells Fargo
Wells Fargo analyst Neil Kalton lowered his price target for PG&E to $47 from $60 to take into account potential wildfire liabilities. The analyst reiterates an Outperform rating on the shares.
01/02/19
MSCO
01/02/19
NO CHANGE
Target $31
MSCO
Equal Weight
Recent developements for PG&E mixed, not entirely negative, says Morgan Stanley
Morgan Stanley analyst Stephen Byrd noted that PG&E shares underperformed large cap U.S. electric utility peers by about 5% in December. He does not view the numerous recent developments involving PG&E as entirely negative, as the stock move would suggest, but rather sees them as "mixed," with some positives, Byrd tells investors. He sees the CPUC Order Instituting Rulemaking regarding the "stress test" as a positive development and also believes the CPUC Scoping Memo released on December 21 is a development with both positive and negative implications for PG&E, Byrd said. There were also several legal developments in December that were a mix of negative and positive, the analyst added. On the negative side, Byrd lists the CPUC SED report into alleged PG&E falsification of records relating to PG&E's Damage Prevention Program. He maintains an Equal Weight rating on PG&E shares with a $31 price target.
01/04/19
GSCO
01/04/19
UPGRADE
Target $63
GSCO
Buy
Edison International upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Michael Lapides upgraded Edison International to Buy while lowering his price target for the shares to $63 from $71. The analyst upgrades the shares after their 15% underperformance versus peers since the 2018 wildfires. He also is more positive on longer term potential PG&E (PCG) risk/reward following its 48% underperformance. Both utilities now price in a "very bearish outcome" of the wildfires, says Lapides. He believes that recent commentary from state officials regarding keeping utility balance sheets healthy implies a potential cost sharing of recent wildfire related liabilities.
FTK Flotek
$1.42

-0.025 (-1.74%)

08/08/18
GHSC
08/08/18
DOWNGRADE
GHSC
Neutral
Flotek downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst Mike Urban downgraded Flotek to Neutral from Buy following the Q2 miss. Urban said "everything that could have gone wrong did" as the company missed "badly" on revenue and margins. The analyst does not see any positive catalysts in the short-to-intermediate term and said shares will likely be "dead money" at best until results improve.
ADM Archer Daniels
$43.38

0.31 (0.72%)

11/08/18
ARGS
11/08/18
UPGRADE
ARGS
Buy
Archer Daniels upgraded to Buy from Hold at Argus
08/16/18
SPHN
08/16/18
NO CHANGE
Target $57
SPHN
Overweight
Archer Daniels price target raised to $57 after Brazilian deal at Stephens
Stephens analyst Farha Aslam noted that terms of Archer Daniels' deal to purchase Brazilian assets from Algar Agro were not disclosed, but she estimates the transaction to be valued at $200M-$300M. Aslam, who sees the deal strengthening Archer Daniels' positioning in the key agriculture market of Brazil, raised her price target on the stock to $57 from $52 and keeps an Overweight rating on Archer Daniels shares.
11/08/18
ARGS
11/08/18
UPGRADE
Target $53
ARGS
Buy
Archer Daniels upgraded to Buy from Hold at Argus
Argus analyst Deborah Ciervo upgraded Archer Daniels to Buy with a price target of $53, citing the company's recent strong performance and improvement in its Oilseeds, Origination, and Nutrition divisions. The analyst also raised his FY18 EPS view by 10c to $3.59 and FY19 view by 8c to $3.66 thanks to the impact of its cost savings efforts. Ciervo has a positive view of the company's long-term strategy, which includes "global expansion through acquisitions and joint ventures, the sale of underperforming businesses, and cost-cutting initiatives".
11/08/18
11/08/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Archer Daniels (ADM) upgraded to Buy from Hold at Argus with analyst Deborah Ciervo citing the company's recent strong performance and improvement in its Oilseeds, Origination, and Nutrition divisions. 2. Ultragenyx (RARE) upgraded to Neutral from Sell at Citi with analyst Yigal Nochomovitz saying his long-standing concerns on Ultragenyx's valuation "have substantially played out with recent pipeline disclosures having rapidly reset the valuation." 3. Medifast (MED) upgraded to Buy from Neutral at Sidoti. 4. Knight-Swift (KNX) upgraded to Buy from Neutral at Goldman Sachs with analyst Matthew Reustle saying he is bullish on Knight citing incremental evidence that the merger with Swift Transportation will deliver margin improvement through the end of the decade, reduced investor expectations following recent estimate revisions, and a view that Knight is more defensive through a down-cycle with a de-risked valuation. 5. Axon (AAXN) Enterprise upgraded to Overweight from Neutral at JPMorgan with analyst Mark Strouse saying the stock pulled back 16% yesterday following the company's Q3 results and guidance that implies a dip in revenue growth during Q4. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GPS Gap
$25.25

-0.8 (-3.07%)

01/02/19
JEFF
01/02/19
NO CHANGE
JEFF
Buy Gap, sell L Brands are Jefferies' best Consumer ideas for 2019
In the Consumer space, Jefferies analyst Randal Konik says his best ideas for 2019 are buying Gap (GPS) and selling L Brands (LB). The analyst recommends using the late 2018 selloff as an opportunity to get long consumer names for 2019. His other top Buy ideas are American Eagle (AEO), Boot Barn (BOOT), Capri Holdings (CPRI), Five Below (FIVE), Foot Locker (FL), Fox Factory (FOXF), Acushnet Holdings (GOLF), Kohl's (KSS), Manchester United (MANU), Ollie's Bargain Outlet (OLLI), Tiffany (TIF), Urban Outfitters (URBN), Under Armour (UAA) and Yeti (YETI). On L Brands, Konik continues to believe Victoria's Secret "is broken," Pink "is a fad" that's sales will get cut in half, and Bath & Body Works is at a "cyclical peak with daunting compares ahead." On the flip side, the analyst thinks Gap will be one of the top S&P 500 stocks in 2019. He recommends "aggressively" buying the shares at current levels.
11/28/18
MKMP
11/28/18
NO CHANGE
Target $30
MKMP
Neutral
Gap price target lowered to $30 from $32 at MKM Partners
MKM Partners analyst Roxanne Meyer lowered her price target on Gap to $30 and kept her Neutral rating after its Q3 earnings last week. The analyst notes that the results were a "mixed bag" with sequentially improving comps but lower gross margin and higher SG&A costs. Meyer adds that Banana Republic is recovering, with consecutive quarters of positive comps and indications of accelerating momentum in Q4, but the Gap brand comps were worse than expected, with the closing of underperforming stores being potentially "just a first step".
01/11/19
LEHM
01/11/19
DOWNGRADE
Target $25
LEHM
Underweight
Gap downgraded to Underweight from Overweight at Barclays
Barclays analyst Chethan Mallela double downgraded Gap to Underweight from Overweight and cut his price target for the shares to $25 from $33. The analyst believes "challenging" traffic trends and "difficult" comparisons cloud visibility into the company's sales growth momentum. Further, the analyst believes the company's cost pressures will be larger than investors anticipate and pose risk to consensus estimates.
12/20/18
WEDB
12/20/18
NO CHANGE
Target $25
WEDB
Neutral
Gap goes 'from naughty to nice' as Big data forecasts inflection, says Wedbush
Wedbush analyst Jen Redding says Gap "goes from naughty to nice" as her firm's Big data forecasts inflection from a gross margin miss into the third-quarter print to a gross margin run-rate now tracking ahead of consensus in mid fourth-quarter. The Black Friday holiday shopping period was strong, and she is now tracking upside to holiday business, as her data model forecasts approximately 90 bps in gross margin upside to 37.28% versus street expectations for 36.34%. Redding reiterates a Neutral rating and $25 price target on the shares.
WTW WW
$35.02

-1.02 (-2.83%)

11/27/18
JPMS
11/27/18
NO CHANGE
Target $70
JPMS
Overweight
Weight Watchers valuation 'decoupled from reality,' says JPMorgan
JPMorgan analyst Christina Brathwaite believes the current valuation of Weight Watchers has "significantly decoupled from its earnings growth reality." The shares currently trade at less than 14 times 2019 earnings estimates despite a 20% earnings growth opportunity in 2019 and 2020, Brathwaite tells investors in a research note after hosting investor meetings with management. The analyst recommends using the recent pullback as a buying opportunity. She keeps an Overweight rating on Weight Watchers with a $70 price target. Brathwaite believes the programs launched to close out this year, combined with plans for a marketing campaign featuring Oprah into the New Year resolution sign up period, should drive a member growth reacceleration in Q1 of 2019.
12/10/18
DADA
12/10/18
NO CHANGE
Target $137
DADA
Buy
Davidson cautious on Weight Watchers Q4, but sees near 'rock-bottom' valuation
DA Davidson analyst Linda Bolton Weiser left a meeting with Weight Watchers CEO Mindy Grossman and CFO Nick Hotchkin "cautious" on the company's Q4. After a "sub-optimal" September, trends made a come-back in October and November, but it was a "negative indicator" when Oprah tweeted the Share the Gift of Health promotion on December 4, Bolton Weiser tells investors in a research note titled "Nearing 'Rock-Bottom' Valuation, In Our View." However, when Weight Watchers reports in February, investor attention will be on the 2019 outlook and not the Q4 results, adds the analyst. And she notes that Grossman was adamant that the power of the 2019 campaign will be stronger than in 2018. Bolton Weiser believes her 2019 revenue growth estimate of 12% is reasonable and that a share catalyst is coming "very soon" as the company expects to announce new major celebrity spokespeople in the U.S. and U.K. in the coming weeks. She believes the stock, at 10.2 times 2020 earnings estimates, is getting "quite close to rock-bottom valuation," which would be $39. The analyst keeps an Outperform rating on the shares with a $137 12-18 month price target.
01/11/19
JPMS
01/11/19
DOWNGRADE
Target $37
JPMS
Neutral
WW downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Christina Brathwaite downgraded WW, formerly known as Weight Watchers, to Neutral and lowered her price target for the shares to $37 from $70. The analyst's early in the year channel checks point to a weak start to 2019 for the company. The checks suggest traffic to WW''s website and engagement on its mobile app are down double-digit percentages year-over-year, Brathwaite tells investors in a research note.
01/08/19
CHLM
01/08/19
NO CHANGE
Target $80
CHLM
Buy
WW price target lowered to $80 from $120 at Craig-Hallum
Craig-Hallum analyst Alex Fuhrman lowered his price target for WW to $80 from $120 as Google searches appear to be down sharply year over year in December and first few days In January. Most major diet brands appear to be experiencing declining year over year Google searches to start the year, with Hydroxycut and Nutrisystem's (NTRI) South Beach Diet standing out with positive year over year growth in searches, he contends. Regarding WW, while the sharp decline in Google searches is disappointing, Fuhrman believes there are several factors that could be materially skewing the data lower, including name change from Weight Watchers to WW, shift toward digital marketing, and invite-a-friend promotion. The analyst reiterates a Buy rating on WW shares.
YUM Yum! Brands
$91.79

0.63 (0.69%)

12/14/18
JPMS
12/14/18
NO CHANGE
Target $182
JPMS
Overweight
JPMorgan calls McDonald's, Yum! Brands 'safe to own' stocks
JPMorgan analyst John Ivankoe believes McDonald's (MCD) and Yum! Brands (YUM) are "safe to own" stocks with continued outperformance expected in a down market. However, for absolute performance, the analyst believes the shares should be bought at lower prices. He keeps an Overweight rating on both names and ticked up his price target for McDonald's to $182 from $180 and for Yum! to $91 from $90.
11/30/18
LBOW
11/30/18
NO CHANGE
Target $325
LBOW
Buy
Pizza Hut $5 offer not having impact on Domino's, says Longbow
Longbow analyst Alton Stump said that his checks with U.S. Domino's Pizza (DPZ) franchisees lead him to believe domestic franchised same-store sales are up 7.5%-8% quarter-to-date in Q4, which he notes is just above the consensus forecast of 7.4% growth for Q4. The franchisees he contacted said they have not seen any noticeable impact from Pizza Hut's (YUM) mid-October launch of its new $5 value platform, Stump noted. He keeps a Buy rating on Domino's shares with a $325 price target.
01/11/19
GSCO
01/11/19
DOWNGRADE
Target $76
GSCO
Sell
Yum! Brands downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Karen Holthouse downgraded Yum! Brands to Sell and lowered her price target for the shares to $76 from $83. The company's "peak valuations versus the market" are "overly dismissive of a number of risks," Holthouse tells investors in a research note. The analyst remains skeptical of a U.S. Pizza Hut recovery and has concerns about Taco Bell momentum "as it starts to lap a more aggressive value push that started in late 2017."

TODAY'S FREE FLY STORIES

PTC

PTC

$84.73

-1.14 (-1.33%)

20:28
01/23/19
01/23
20:28
01/23/19
20:28
Recommendations
PTC analyst commentary  »

PTC price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

UNP

Union Pacific

$154.20

-0.8 (-0.52%)

, BMY

Bristol-Myers

$49.92

0.21 (0.42%)

20:25
01/23/19
01/23
20:25
01/23/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

UNP

Union Pacific

$154.20

-0.8 (-0.52%)

BMY

Bristol-Myers

$49.92

0.21 (0.42%)

LUV

Southwest

$50.97

0.425 (0.84%)

MKC

McCormick

$139.03

0.31 (0.22%)

FCX

Freeport McMoRan

$12.30

-0.08 (-0.65%)

GWW

Grainger

$297.12

-3.29 (-1.10%)

AAL

American Airlines

$31.57

-1.18 (-3.60%)

HBAN

Huntington Bancshares

$13.56

0.05 (0.37%)

TXT

Textron

$49.19

0.76 (1.57%)

JBLU

JetBlue

$17.23

-0.13 (-0.75%)

AEP

American Electric

$77.00

0.65 (0.85%)

TAL

TAL Education

$31.21

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 28

    Jan

  • 07

    Feb

  • 18

    Feb

  • 28

    Feb

  • 18

    May

  • 20

    May

ADTN

Adtran

$12.25

0.49 (4.17%)

20:14
01/23/19
01/23
20:14
01/23/19
20:14
Earnings
Adtran reports Q4 adjusted EPS (12c), consensus (3c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MSFT

Microsoft

$106.77

0.91 (0.86%)

, GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

20:10
01/23/19
01/23
20:10
01/23/19
20:10
Periodicals
China blocks Microsoft's Bing search engine, FT reports »

China regulators have…

MSFT

Microsoft

$106.77

0.91 (0.86%)

GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

BIDU

Baidu

$163.22

2.81 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 30

    Jan

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

EBAY

eBay

$32.62

-0.3 (-0.91%)

20:03
01/23/19
01/23
20:03
01/23/19
20:03
Recommendations
eBay analyst commentary  »

eBay should consider…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

CLR

Continental Resources

$45.30

-0.27 (-0.59%)

20:00
01/23/19
01/23
20:00
01/23/19
20:00
Conference/Events
Continental Resources to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

APY

Apergy

$33.20

-0.35 (-1.04%)

19:55
01/23/19
01/23
19:55
01/23/19
19:55
Initiation
Apergy initiated  »

Apergy initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

  • 19

    Feb

AMZN

Amazon.com

$1,641.50

7.35 (0.45%)

19:15
01/23/19
01/23
19:15
01/23/19
19:15
Hot Stocks
AWS unveils Amazon WorkLink solution »

Amazon Web Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 28

    Jan

  • 31

    Jan

  • 04

    Feb

  • 20

    Feb

  • 03

    Mar

SMBK

SmartFinancial

$18.35

0.21 (1.16%)

19:08
01/23/19
01/23
19:08
01/23/19
19:08
Earnings
SmartFinancial reports Q4 operating EPS 43c, consensus 37c »

SmartFinancial Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MLRYY

Mail.Ru Group

$0.00

(0.00%)

19:05
01/23/19
01/23
19:05
01/23/19
19:05
Downgrade
Mail.Ru Group rating change  »

Mail.Ru Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$152.03

-0.1 (-0.07%)

18:58
01/23/19
01/23
18:58
01/23/19
18:58
Periodicals
Zhongnan Group to buy Alibaba-backed EasyHome for CNY38B, Bloomberg says »

Alibaba owns a 15% stake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 03

    Mar

  • 04

    Mar

JPM

JPMorgan

$102.72

-0.23 (-0.22%)

18:55
01/23/19
01/23
18:55
01/23/19
18:55
Periodicals
JPMorgan exec says private bank expands ops in Mexico, Reuters says »

JPMorgan's private…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SLM

Sallie Mae

$9.49

0.1 (1.07%)

, XLNX

Xilinx

$89.55

-0.89 (-0.98%)

18:53
01/23/19
01/23
18:53
01/23/19
18:53
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: SLM…

SLM

Sallie Mae

$9.49

0.1 (1.07%)

XLNX

Xilinx

$89.55

-0.89 (-0.98%)

AZPN

Aspen Technology

$89.08

0.22 (0.25%)

LRCX

Lam Research

$139.24

-0.58 (-0.41%)

URI

United Rentals

$115.98

-2.21 (-1.87%)

TER

Teradyne

$31.93

0.13 (0.41%)

VAR

Varian Medical

$126.83

1.57 (1.25%)

CP

Canadian Pacific

$195.71

0.02 (0.01%)

TXN

Texas Instruments

$95.49

-1.05 (-1.09%)

F

Ford

$8.34

-0.17 (-2.00%)

BGG

Briggs & Stratton

$13.73

-0.46 (-3.24%)

PTC

PTC

$84.73

-1.14 (-1.33%)

CTXS

Citrix

$108.64

0.4 (0.37%)

LVS

Las Vegas Sands

$57.25

0.26 (0.46%)

FFIV

F5 Networks

$159.65

2.5 (1.59%)

CCI

Crown Castle

$110.28

1.13 (1.04%)

NCNA

NuCana

$14.37

-0.38 (-2.58%)

ADXS

Advaxis

$0.32

-0.0283 (-8.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 28

    Jan

  • 28

    Jan

  • 29

    Jan

  • 29

    Jan

  • 30

    Jan

  • 11

    Feb

  • 14

    Feb

  • 25

    Feb

  • 25

    Mar

  • 26

    Mar

  • 25

    Apr

  • 28

    May

  • 24

    Jul

  • 23

    Oct

  • 25

    Jan

FB

Facebook

$144.35

-3.45 (-2.33%)

18:41
01/23/19
01/23
18:41
01/23/19
18:41
Periodicals
Advocacy groups pushing FTC to force Facebook breakup, WSJ says »

Multiple advocacy groups…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 25

    Feb

  • 03

    Mar

GOOG

Alphabet

$1,076.04

5.32 (0.50%)

, GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

18:38
01/23/19
01/23
18:38
01/23/19
18:38
Periodicals
Devs say Google's Chrome proposal threatens ad blockers, Bloomberg says »

Developers are…

GOOG

Alphabet

$1,076.04

5.32 (0.50%)

GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

FCPT

Four Corners Property Trust

$26.58

-0.09 (-0.34%)

, BLMN

Bloomin' Brands

$19.15

0.08 (0.42%)

18:36
01/23/19
01/23
18:36
01/23/19
18:36
Recommendations
Four Corners Property Trust, Bloomin' Brands analyst commentary  »

Four Corners Property…

FCPT

Four Corners Property Trust

$26.58

-0.09 (-0.34%)

BLMN

Bloomin' Brands

$19.15

0.08 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

BAC

Bank of America

$28.91

-0.18 (-0.62%)

18:11
01/23/19
01/23
18:11
01/23/19
18:11
Periodicals
Bank of America appoints Mike Joo as investment operating chief, Reuters says »

Head of global rates and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

  • 03

    Mar

F

Ford

$8.34

-0.17 (-2.00%)

18:08
01/23/19
01/23
18:08
01/23/19
18:08
Hot Stocks
Ford says Russian alliance 'under review' »

Says won't have to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

F

Ford

$8.34

-0.17 (-2.00%)

18:04
01/23/19
01/23
18:04
01/23/19
18:04
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford says 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

CHMG

Chemung Financial

$41.99

-0.11 (-0.26%)

18:04
01/23/19
01/23
18:04
01/23/19
18:04
Earnings
Chemung Financial reports Q4 EPS $1.18, consensus $1.04 »

Reports Q4 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.34

-0.17 (-2.00%)

18:03
01/23/19
01/23
18:03
01/23/19
18:03
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford says 2019 will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

F

Ford

$8.34

-0.17 (-2.00%)

18:01
01/23/19
01/23
18:01
01/23/19
18:01
Hot Stocks
Ford says 2018 auto EBIT benefited from improvement of market factors »

Says auto EBIT in 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

HSIC

Henry Schein

$76.92

-0.45 (-0.58%)

17:56
01/23/19
01/23
17:56
01/23/19
17:56
Hot Stocks
Henry Schein falls after saying it will not be key supplier to VCA,Pet Partners »

Shares of Henry Schein…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSIC

Henry Schein

$76.92

-0.45 (-0.58%)

17:51
01/23/19
01/23
17:51
01/23/19
17:51
Hot Stocks
Henry Schein will no longer be key supplier to VCA and Pet Partners »

Mars, Incorporated has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLX

Hologic

$44.40

0.22 (0.50%)

17:50
01/23/19
01/23
17:50
01/23/19
17:50
Hot Stocks
Hologic says FDA grants clearance for Aptima Mycoplasma genitalium assay »

Hologic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.